Lifetime measures of cannabis use and co-occurring exposures were obtained from a longitudinal cohort followed an average of 13 years at the time they received a structural MRI scan. MRI scans were analyzed for 88 participants (mean age¼25.9 years), 34 of whom were regular users of cannabis. Whole brain voxel based morphometry analyses (SPM8) were conducted using 50 voxel clusters at p ¼0.005. Controlling for age, familial risk, and gender, we found reduced volume in Regular Users compared to NonUsers, in the lingual gyrus, anterior cingulum (right and left), and the rolandic operculum (right). The right anterior cingulum reached family-wise error statistical significance at p ¼0.001, controlling for personal lifetime use of alcohol and cigarettes and any prenatal exposures. CNR1 haplotypes were formed from four CNR1 SNPs (rs806368, rs1049353, rs2023239, and rs6454674) and tested with level of cannabis exposure to assess their interactive effects on the lingual gyrus, cingulum (right and left) and rolandic operculum, regions showing cannabis exposure effects in the SPM8 analyses. These analyses used mixed model analyses (SPSS) to control for multiple potentially confounding variables. Level of cannabis exposure was associated with decreased volume of the right anterior cingulum and showed interaction effects with haplotype variation.
Introduction
The 2013 National Survey on Drug Use and Health (NSDUH) (SAMHSA 2014) reported that marihuana is the most commonly used illicit drug in persons age 12 or older with 19.8 million individuals in the US reporting use in the past month. Daily use climbed from 5.1 million persons in 2007 to 8.1 million in 2013. The Monitoring the Future survey (Johnston et al., 2013) revealed that by 12th grade 36% of students report using marihuana in the past month, with daily use reported by 6%. A number of consequences of marihuana use present public health concerns. Of particular importance is the possible lasting effects on brain structure and functioning that occur in association with marihuana use. Despite evidence pointing to health problems in association with long-term cannabis use (Murray et al., 2007; Hall and Solowij, 1998) , the dose-dependent effects of cannabis use on brain morphology have been assessed in only a few human studies. Moreover, documenting the relationship between cannabis use and brain alteration has been challenging because cannabis users tend to be users of other commonly used drugs such as alcohol and cigarettes.
The heritability of ever using cannabis or becoming dependent on it is moderately high (between 17-76%), suggesting that cannabis use behaviors have genetic underpinnings (Agarwal and Lynskey, 2006 for review). There are two known receptors within the endocannabinoid system. The cannabinoid receptor 1 (Human Gene Nomenclature Committee [HUGO approved symbol CNR1]) and alternatively known as CB1, has a cytogenetic location at chromosome 6q15 and is found throughout the brain where it is highly expressed (Childers and Breivogel, 1998) while the cannabinoid receptor 2 (CNR2), also known as CB2 appears to be confined to the periphery. Type I cannabinoid receptors have been localized to multiple brain regions including the prefrontal cortex, amygdala, hippocampus, striatum, and cerebellum (Herkenham et al., 1991; Eggan and Lewis, 2007) . The cannabinoid gene (CNR1) encodes for CB1 receptor making it an ideal candidate gene for studying cannabis exposure effects.
Cannabis use has been associated with reduction of volume in a number of brain regions, particularly those rich in cannabinoid CB1 receptors, including the medial temporal cortex, parhippocampal gyrus (Matochik et al., 2005) 
